Sort
15,842 grants matching “pancreatic cancer”
SPORE IN GASTOINTESTINAL CANCER
$250,000University Of Nebraska Medical Center · P50 · FY2004 · CA
PFI-TT: Point-of-Care Sensor Based on Electric Fields and Machine Learning for the Detection of Circulating MicroRNA to Identify Early Stage Pancreatic Cancer
$250,000Dharmakeerthi Nawarathna · North Dakota State University Fargo · · FY2022 · TIP
Ph1 Study of T-Vec given endoscopically for advanced pancreatic cancer IN 17248 (11/21/2016)
$250,000Yvonne Margaret Saenger · Columbia University Health Sciences · R01 · FY2018 · FD
Ph1 Study of T-Vec given endoscopically for advanced pancreatic cancer IN 17248 (11/21/2016)
$250,000Yvonne Margaret Saenger · Columbia University Health Sciences · R01 · FY2019 · FD
UNMC Eppley Cancer Center Support Grant
$250,000University Of Nebraska Medical Center · P30 · FY2004 · CA
Contract Title: SBIR Phase I Topic 324 Development of an Imaging Agent Targeting
$249,965Wolfgang Scholz · Mabvax Therapeutics, Inc. · N43 · FY2013 · CA
A novel oncolytic virus for pancreatic cancer immunotherapy
$249,900Omeed Moaven · Lsu Health Sciences Center · P20 · FY2024 · GM
Chemotherapy of Pancreatic Cancer: Induction of Apoptosis or Senescence
$249,885David E Modrak · Ctr For Molecular Medicine/Immunology · R21 · FY2008 · CA
Reflux-Induced Epithelial-Mesenchymal Transition in Benign Barrett's Esophagus
$249,865Rhonda F Souza · Baylor Research Institute · R01 · FY2016 · DK
Role of Gastrin in the Pathogenesis of Colorectal Cancer
$249,738Michael Wolfe · Boston Medical Center · R01 · FY2007 · CA
Role of Gastrin in the Pathogenesis of Colorectal Cancer
$249,738Michael Wolfe · Boston Medical Center · R01 · FY2008 · CA
IMMUNOMODULATION OF TRANSPLANT REJECTION BY ANTI-CD3 MAB
$249,729University Of California San Francisco · R37 · FY2004 · AI
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER
$249,664University Of California Irvine · R01 · FY2002 · CA
EPIDERMAL GROWTH FACTOR RECEPTORS AND PANCREATIC CANCER
$249,664University Of California Irvine · R01 · FY2003 · CA
IGF::OT::IGF SBIR Phase I Topic 356 Flourogenic assay platform for circular RNA detectionPoP 9/18/2017 - 6/18/2018.
$249,642Balajee Somalinga · Lucerna, Inc. · N43 · FY2017 · CA
SBIR TOPIC 257, INSTRUMENTS AND DEVICES THAT PRESERVE MOLECULAR PROFILES IN TUMO
$249,614Mark Johnson · Phoenix Analysis And Design Technologies · N43 · FY2009 · CA
High Definition Clonal Analyses of Archival Pancreatic Adenocarcinoma Samples
$249,584Michael T Barrett · Translational Genomics Research Inst · R21 · FY2011 · CA
Comprehensive Cancer Center Core Support Grant
$249,574Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2009 · CA
OTHER FUNCTIONS R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPME
$249,525Thomas Zupancic · Enlyton, Ltd · N43 · FY2012 · CA
The Oral Mycobiome and Risk of Pancreatic Cancer
$249,426Jiyoung Ahn · New York University School Of Medicine · U01 · FY2023 · CA
Theory of Protein-Protein Association
$249,416Huan-Xiang Zhou · Florida State University · R01 · FY2011 · GM
Pancreatic cancer prevention with NO-releasing NSAIDs
$249,347Basil Rigas · State University New York Stony Brook · R01 · FY2008 · CA
Pancreatic cancer prevention with NO-releasing NSAIDs
$249,347Basil Rigas · State University New York Stony Brook · R01 · FY2007 · CA
TAS::75 0849::TAS SBIR TOPIC 307 PHASE I NOVEL IMAGING AGENTS TO EXPAND THE CLIN
$249,330Greg Fralish · Iti Health, Inc. · N43 · FY2011 · CA
Apoptosis Inducing to Enhance Tumor Targeting
$249,199Optimum Therapeutics, Llc · R43 · FY2004 · CA